The results of Western blot analysis and indirect immunofluorescence indicated that the expression of CTSB protein reduced after TSPN gavage treatment in a dose-dependent manner compared with the tumor-bearing group (Figs. 4, 5 and 6). This evidence concerns the gene CTSB and neoplasm.